A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal – author response

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1006
Number of pages1
JournalBritish Journal of Dermatology
Volume177
Issue number4
DOIs
Publication statusPublished - Oct 2017

Bibliographical note

Funding Information:
Original study1 was funded by Novartis.

Cite this